Literature DB >> 27425396

Retina-derived POU domain factor 1 coordinates expression of genes relevant to renal and neuronal development.

Antonio Fiorino1, Giacomo Manenti2, Beatrice Gamba2, Gabriele Bucci3, Loris De Cecco4, Michele Sardella2, Giacomo Buscemi5, Sara Ciceri2, Maria T Radice6, Paolo Radice2, Daniela Perotti2.   

Abstract

Retina-derived POU domain Factor 1 (RPF-1), a member of POU transcription factor family, is encoded by POU6F2 gene, addressed by interstitial deletions at chromosome 7p14 in Wilms tumor (WT). Its expression has been detected in developing kidney and nervous system, suggesting an early role for this gene in regulating development of these organs. To investigate into its functions and determine its role in transcriptional regulation, we generated an inducible stable transfectant from HEK293 cells. RPF-1 showed nuclear localization, elevated stability, and transactivation of promoters featuring POU consensus sites, and led to reduced cell proliferation and in vivo tumor growth. By addressing the whole transcriptome regulated by its induction, we could detect a gross alteration of gene expression that is consistent with promoter occupancy predicted by genome-wide Chip-chip analysis. Comparison of bound regulatory regions with differentially expressed genes allowed identification of 217 candidate targets. Enrichment of divergent octamers in predicted regulatory regions revealed promiscuous binding to bipartite POUS and POUH consensus half-sites with intervening spacers. Gel-shift competition assay confirmed the specificity of RPF-1 binding to consensus motifs, and demonstrated that the Ser-rich region upstream of the POU domain is indispensable to achieve DNA-binding. Promoter-reporter activity addressing a few target genes indicated a dependence by RPF-1 on transcriptional response. In agreement with its expression in developing kidney and nervous system, the induced transcriptome appears to indicate a function for this protein in early renal differentiation and neuronal cell fate, providing a resource for understanding its role in the processes thereby regulated.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Chromatin immunoprecipitation (ChiP); DNA binding protein; Developmental factor; Gene expression; POU transcription factor; Wilms tumor

Mesh:

Substances:

Year:  2016        PMID: 27425396     DOI: 10.1016/j.biocel.2016.07.013

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  4 in total

1.  Identification of a novel somatic mutation of POU6F2 by whole-genome sequencing in prolactinoma.

Authors:  Yazhou Miao; Chuzhong Li; Jing Guo; Hongyun Wang; Lei Gong; Weiyan Xie; Yazhuo Zhang
Journal:  Mol Genet Genomic Med       Date:  2019-11-06       Impact factor: 2.183

2.  Asynchronous excitatory neuron development in an isogenic cortical spheroid model of Down syndrome.

Authors:  Zhen Li; Jenny A Klein; Sanjeev Rampam; Ronni Kurzion; Natalie Baker Campbell; Yesha Patel; Tarik F Haydar; Ella Zeldich
Journal:  Front Neurosci       Date:  2022-09-07       Impact factor: 5.152

3.  Restricted Presence of POU6F2 in Human Corneal Endothelial Cells Uncovered by Extension of the Promoter-level Expression Atlas.

Authors:  Masahito Yoshihara; Susumu Hara; Motokazu Tsujikawa; Satoshi Kawasaki; Yoshihide Hayashizaki; Masayoshi Itoh; Hideya Kawaji; Kohji Nishida
Journal:  EBioMedicine       Date:  2017-11-04       Impact factor: 8.143

4.  Genomic locus modulating corneal thickness in the mouse identifies POU6F2 as a potential risk of developing glaucoma.

Authors:  Rebecca King; Felix L Struebing; Ying Li; Jiaxing Wang; Allison Ashley Koch; Jessica N Cooke Bailey; Puya Gharahkhani; Stuart MacGregor; R Rand Allingham; Michael A Hauser; Janey L Wiggs; Eldon E Geisert
Journal:  PLoS Genet       Date:  2018-01-25       Impact factor: 5.917

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.